Theratechnolgies Inc

Website Links

Description

A graduate of Université Laval, Pierre Perazzelli has more than 20 years of experience in the pharmaceutical manufacturing industry. Throughout his career, he has held various positions in large pharmaceutical companies, such as Bristol Myers Squibb and Abbott Laboratories. He was Director of the LAB Laboratory, a research centre specializing in pharmaceutical formulation. He is also experienced in the production of generic drugs. Mr. Perazzelli joined Theratechnologies in May 2000.

Luc Tanguay has been active in the biotechnology industry for over 20 years. As a member of senior management at Theratechnologies since 1996, he has contributed to the Company’s growth by facilitating access to public and private capital funding. A member of the Board of Directors since 1993, he has held various management posts since joining the Company. Prior to joining Theratechnologies, Mr. Tanguay had a successful career in investment banking at Lévesque Beaubien (now National Bank Financial) where he helped several organizations establish themselves as public companies.

Mrs. Fortin has over 27 years of experience in the commercialization of pharmaceutical products for human health. She has been in executive level positions at Merck Canada for 13 years until 2011. In these roles she was responsible for Marketing and Sales of product portfolios in diverse therapeutic areas. She also managed all the commercial support functions which included marketing and sales research, sales training, sales operations, manufacturing planning, Office of Compliance, Sigma and change management.

Dr. Gilles Cloutier has over 35 years of experience in the development and commercialization of drugs for various therapeutic applications. He was primarily responsible for the development and commercialization of Tracrium, Lamictal and Remodulin in the United States. He was a founder and a director of various biotech and contract research organizations, including United Therapeutics Corporation where he served as Chief Business Officer and Chief Financial Officer between 1997 and 2001.

Dr. Christian Marsolais has over 15 years of experience in clinical research for large pharmaceutical companies, such as Sandoz Canada and BioChem Therapeutics. Before joining Theratechnologies in 2007, Dr. Marsolais held various positions at Pfizer Global Pharmaceuticals, where he was appointed Director of Medical Affairs, Therapeutic Areas, in 2004. In this position, Dr. Marsolais was responsible for the clinical program and the development of scientific initiatives, as well as the integration of the Scientific Affairs and Clinical Research for the Oncology and HIV Franchise. Dr.

Products & services

Similar companies nearby